Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Incorporating alternative investments into your long-term portfolio can enhance diversification and improve returns.
27,567 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
A fintech stock surged in recent years, then faced a pullback during down weeks. This article outlines a disciplined ...
Insider stock moves can tell a story, but one sale isn’t the whole chapter. This guide breaks down what a merit medic...
Hut 8 is shifting from pure mining to an infrastructure landlord role, using long-term leases, project debt, and BTC ...
Broadcom stock surged on AI optimism, then slipped after earnings. This guide explains how to evaluate a dip, what ri...
Six weeks of fund outflows from US spot BTC ETFs weigh on Bitcoin as the price drops to 21-month lows. Long-term hold...
Ethereum trades near $1,780 as Vitalik Buterin outlines Lean Ethereum, a multi-year overhaul that could redefine data...
In May, Figma delivered a performance surge that surprised many investors. This article breaks down the key drivers b...
A major fund recently disclosed a sizable stake in Boston Properties, sparking questions about what this move signals...
A high-profile pause from acting can be priceless—and financially smart. Learn how Joan Cusack’s break offers lessons...
As the week nears its end, Thursday often brings a fresh wave of data and earnings that can move markets. This guide ...
A Sunrun co-founder disclosed the sale of 50,000 shares, prompting questions about timing and implications. This arti...